Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors.
Yeun-Yoon KimJeeyun LeeWoo Kyoung JeongSeung Tae KimJae-Hun KimJung Yong HongWon Ki KangKyoung-Mee KimInsuk SohnDongil ChoiPublished in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2020)
CT-determined sarcopenia is an independent prognostic factor for PFS in patients with MSS GC treated with PD-1 inhibitors.